Monsanto Loses Key Biotech Lawsuit In Europe

Law360, New York (December 3, 2003, 12:00 AM EST) -- Monsanto Co. has lost one patent battle over a key technology used in genetically modifying plants, but says litigation in the U.S. will clarify its intellectual property rights in a long-running dispute with German researchers, the St. Louis Post-Dispatch reported.

Last week, the European Patent Office issued a patent for

agrobacterium-transformation technology to the Max Planck Society, a German research organization. The society gave an exclusive license to Monsanto’s German competitor Bayer CropScience.

Agrobacterium transformation technology allows scientists to transfer a gene into a host plant's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.